Histogen Inc. short interest in 2019
In 2019, Histogen Inc.'s disclosed short interest ran from 9.27% of shares outstanding on 15 Jan 2019 to 2.80% on 31 Dec 2019, a change of -6.47 percentage points. The year's high was 13.76% on 15 Apr 2019 and its low 2.35% on 15 Nov 2019, averaging 7.49% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.58 days on 14 Jun 2019. Full history: Histogen Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2019 in figures
- Start of year
- 9.27% (15 Jan 2019)
- End of year
- 2.80% (31 Dec 2019)
- Change
- -6.47 pp
- High
- 13.76% (15 Apr 2019)
- Low
- 2.35% (15 Nov 2019)
- Average
- 7.49%
- Highest days to cover
- 26.58 (14 Jun 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 9.27% | 4.92 | |
| 31 Jan 2019 | 9.93% | 4.43 | |
| 15 Feb 2019 | 10.82% | 6.96 | |
| 28 Feb 2019 | 9.81% | 6.86 | |
| 15 Mar 2019 | 10.08% | 2.18 | 10-K filed, results (8-K) |
| 29 Mar 2019 | 11.73% | 2.18 | |
| 15 Apr 2019 | 13.76% | 2.58 | |
| 30 Apr 2019 | 12.71% | 4.20 | |
| 15 May 2019 | 11.85% | 9.99 | results (8-K), 10-Q filed |
| 31 May 2019 | 10.71% | 19.29 | |
| 14 Jun 2019 | 11.24% | 26.58 | |
| 28 Jun 2019 | 8.38% | 1.16 | |
| 15 Jul 2019 | 6.16% | 1.00 | |
| 31 Jul 2019 | 5.73% | 2.71 | |
| 15 Aug 2019 | 5.84% | 3.26 | results (8-K), 10-Q filed |
| 30 Aug 2019 | 5.48% | 3.35 | |
| 13 Sep 2019 | 3.85% | 1.00 | |
| 30 Sep 2019 | 3.82% | 2.30 | |
| 15 Oct 2019 | 4.97% | 3.16 | |
| 31 Oct 2019 | 3.29% | 1.67 | |
| 15 Nov 2019 | 2.35% | 2.92 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 2.38% | 1.86 | |
| 13 Dec 2019 | 2.74% | 1.65 | |
| 31 Dec 2019 | 2.80% | 2.40 |
See also: Histogen Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.